vimarsana.com

சபை நிரந்தர பிரதிநிதிகள் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Payments Newsletter, July 2021 | Hogan Lovells

Europe: EBA consults on proposed guidelines on limited network exclusion under PSD2 On 15 July 2021, the EBA published a consultation paper (EBA/CP/2021/28) proposing guidelines on the limited network exclusion (LNE) under PSD2. The EBA explains that Article 3(k) of PSD2 introduced an exclusion for services based on specific payment instruments that can be used only in a limited way. It believes that the implementation and application of the LNE requirements diverges significantly between member states, which impedes the single market for payment services in the EU and creates opportunities for regulatory arbitrage. The EBA also believes that consumers are sometimes unaware that they do not benefit from the protection envisaged under PSD2.

Coronavirus: Commission proposes update to co-ordinated travel measures ahead of the summer

The European Commission has proposed an update to the Council Recommendation on the coordination of free movement restrictions in the EU, which were put in place in response to the COVID-19 pandemic. As the epidemiological situation is improving and vaccination campaigns are speeding up all over the EU, the Commission is proposing that Member States […]

Additional manufacturing capacity for BioNTech/Pfizer s COVID-19 vaccine

Additional manufacturing capacity for BioNTech/Pfizer’s COVID-19 vaccine Published 1 min ago EMA has recommended the approval of additional manufacturing and filling lines at Pfizer’s vaccine manufacturing site in Puurs, Belgium. The recommendation by the Agency’s Committee for Human Medicines (CHMP) is expected to have a significant and immediate impact on the supply of Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer, in the European Union. Based on the review of the data submitted by BioNTech Manufacturing GmbH, EMA’s decision reaffirms that the Puurs facility is capable of consistently producing high-quality vaccines and enables Pfizer/BioNTech to increase the volumes of vaccines produced at this site.

Coronavirus: Commission proposes update to coordinated travel measures ahead of the summer

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.